FDA Approvals for CME

• FDA Approvals: Use of Oseltamivir Extended to Infants
  Medscape Education Clinical Briefs January 23, 2013
  The US Food and Drug Administration has approved an expanded use of oseltamivir to treat influenza in children as young as 2 weeks old with symptoms for not longer than 2 days.
  
  Save
• FDA Approvals: Pasireotide for Cushing's Disease
  Medscape Education Clinical Briefs January 15, 2013
  The US Food and Drug Administration approved pasireotide, a somatostatin analogue, for treatment of Cushing's disease for patients in whom surgery is not indicated or is unsuccessful.
  
  Save
• FDA Approvals: Varizig to Reduce Severity of Chickenpox Infections
  Medscape Education Clinical Briefs January 09, 2013
  The US Food and Drug Administration approved a new immune globulin preparation to reduce symptoms of the varicella-zoster virus, which causes chickenpox in children and shingles in adults.
  
  Save
• FDA Approvals: Cabozantinib for Medullary Thyroid Cancer
  Medscape Education Clinical Briefs December 10, 2012
  The US Food and Drug Administration has approved cabozantinib, a tyrosine kinase inhibitor, for the treatment of medullary thyroid cancer.
  
  Save
• FDA Approvals: First Cell Culture Influenza Vaccine
  Medscape Education Clinical Briefs December 03, 2012
  The US Food and Drug Administration has approved the first seasonal inactivated influenza vaccine in the United States to use cultured animal cells rather than fertilized chicken eggs.
  
  Save
• FDA Approvals: Tofacitinib for Rheumatoid Arthritis
  Medscape Education Clinical Briefs November 29, 2012
  The US Food and Drug Administration has approved tofacitinib for adults with moderately to severely active rheumatoid arthritis whose condition has responded poorly to methotrexate.
  
  Save
• FDA Approvals: Perampanel for Partial-Onset Seizures
  Medscape Education Clinical Briefs December 20, 2012
  The FDA has approved perampanel for the treatment of partial-onset seizures in patients 12 years and older with epilepsy, to help improve seizure control.
  
  Save
• FDA Approvals: Topical Suspension Approved for Body Plaque Psoriasis
  Medscape Education Clinical Briefs November 15, 2012
  A new combination topical suspension has been approved for body plaque psoriasis.
  
  Save
• FDA Approvals: Albumin-Bound Paclitaxel for Lung Cancer
  Medscape Education Clinical Briefs November 06, 2012
  
  Save
• FDA Approvals: Expanded Label of Pemetrexed for Lung Cancer
  Medscape Education Clinical Briefs October 31, 2012
  The US Food and Drug Administration has expanded the labeling of pemetrexed to include continuation maintenance for patients with stage III/BIV nonsquamous non-small-cell lung cancer.
  
  Save
• FDA Approvals: Ocriplasmin for Vitreomacular Adhesions
  Medscape Education Clinical Briefs October 31, 2012
  The US Food and Drug Administration approved ocriplasmin intravitreal injection as the first nonsurgical treatment alternative for vitreomacular adhesions.
  
  Save
• FDA Approvals: New Drug for Metastatic Colorectal Cancer
  Medscape Education Clinical Briefs October 12, 2012
  A novel multikinase inhibitor is the second drug approved for patients with colorectal cancer in the last 2 months.
  
  Save
• FDA Approvals: Aflibercept Injection for Macular Edema After CRVO
  Medscape Education Clinical Briefs October 09, 2012
  The US Food and Drug Administration has approved aflibercept injection for treating macular edema after central retinal vein occlusion.
  
  Save
• FDA Approvals: First Ultrasound Tool for Dense Breasts
  Medscape Education Clinical Briefs October 03, 2012
  The US Food and Drug Administration has approved a new automated ultrasound device as an adjunct to mammography in the detection of breast cancer in women with dense breast tissue.
  
  Save
• FDA Approvals: New PET Imaging Agent for Prostate Cancer
  Medscape Education Clinical Briefs October 02, 2012
  The US Food and Drug Administration has approved a new positron emission tomography agent to detect recurrent prostate cancer.
  
  Save
• FDA Approvals: Teriflunomide for Relapsing Multiple Sclerosis
  Medscape Education Clinical Briefs October 11, 2012
  The US Food and Drug Administration has approved a second oral agent, teriflunomide, for treatment of relapsing forms of multiple sclerosis.
  
  Save
• FDA Approvals: New Agent for Chronic Myeloid Leukemia
  Medscape Education Clinical Briefs September 17, 2012
  A new agent has been approved by the FDA for patients with chronic myeloid leukemia who have failed treatment with imatinib.
  
  Save
• FDA Approvals: Enzalutamide for Treatment of Advanced Prostate Cancer
  Medscape Education Clinical Briefs September 13, 2012
  The US Food and Drug Administration has approved Enzalutamide, a member of a new class of androgen inhibitors, for patients with recurrent or metastatic prostate cancer.
  
  Save
• FDA Approvals: Tbo-Filgrastim for Neutropenia
  Medscape Education Clinical Briefs September 28, 2012
  The FDA has approved tbo-filgrastim for the treatment of severe neutropenia associated with use of chemotherapy in nonmyeloid malignancies.
  
  Save
• FDA Approvals: Linaclotide for Chronic Constipation, IBS
  Medscape Education Clinical Briefs September 28, 2012
  The FDA has approved linaclotide for treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
  
  Save